Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Esophageal Squamous Cell Carcinoma × Alpelisib × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 22 Neoplasm Metastasis 5 Triple Negative Breast Neoplasms 2 Recurrence 2 Ovarian Neoplasms 2 Multiple Endocrine Neoplasia Type 1 2 Lymphatic Abnormalities 2 Lymphangioma, Cystic 2 Lymphangioma 2 Hyperglycemia 2 Hereditary Sensory and Autonomic Neuropathies 2 Endometrial Neoplasms 2 Vascular Malformations 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Diseases, Vascular 1 Hormone Receptor Positive Breast Carcinoma 1 Head and Neck Squamous Cell Cancer 1 Head and Neck Neoplasms 1 HER2-positive Metastatic Breast Cancer 1 Genetic Diseases, Inborn 1 Fallopian Tube Neoplasms 1 Arteriovenous Malformations 1 Advanced HER2+Breast Cancer 1 Advanced Breast Cancer 1

Interventions

Cisplatin 22 Paclitaxel 17 pembrolizumab 14 Carboplatin 12 Radiotherapy 11 tislelizumab 9 Drug Therapy 9 Fluorouracil 8 toripalimab 7 Nivolumab 7 Irinotecan 7 Esophagectomy 6 Neoadjuvant Therapy 5 Docetaxel 5 Radiation 4 Oxaliplatin 4 Capecitabine 4 Albumin-Bound Paclitaxel 4 130-nm albumin-bound paclitaxel 4 nimotuzumab 3 lenvatinib 3 Taxes 3 Levoleucovorin 3 Leucovorin 3 spartalizumab 2 sintilimab 2 regorafenib 2 nedaplatin 2 durvalumab 2 apatinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡